SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Activity

36 hedge funds and large institutions have $19.2M invested in Salarius Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 17 closing their positions.

Holders
36
Holders Change
-10
Holders Change %
-21.74%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
13
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Ameriprise
1
Ameriprise
Minnesota
$2.52M
2
Primecap Management
2
Primecap Management
California
$6.07M
3
RA
3
Royce & Associates
New York
$1.2M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$171K
5
Millennium Management
5
Millennium Management
New York
$530K

Top Sellers

1
BlackRock
1
BlackRock
New York
$193K
2
State Street
2
State Street
Massachusetts
$0
3
SIM
3
Spark Investment Management
New York
$0
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.02M
5
TCIM
5
TIAA CREF Investment Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
51
Citigroup
New York
– – -14 Closed
IA
52
IFP Advisors
Florida
$0 100 – –
LTFS
53
Ladenburg Thalmann Financial Services
Florida
$0 100 – –
1 2
3